stockrowSchrodinger, Inc.
SDGR Healthcare Health Information Services
Schrodinger, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $255.9 million, up 23.3% from fiscal 2024.
- Revenue
- +18.7%
- EPS
- −11.1%
- Free cash flow
- +21.6%
Quarter to September 2026, against a year earlier
Follow SDGR
Alert me
Schrodinger, Inc. (SDGR) EPS (diluted)
Schrodinger, Inc.'s EPS (diluted) for fiscal 2025 was −$1.41, compared with −$2.57 in fiscal 2024. Over the twelve months to 30 September 2026 it was −$0.79. Over the past ten years it has ranged from −$4.93 (fiscal 2018) to $0.54 (fiscal 2023); the current reading is higher than 67% of that period. Schrodinger, Inc. ranks 23rd of 42 Health Information Services companies by EPS (diluted).
EPS (diluted), annual
Embed this chart
Annual newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| FY2025 | −$1.41 | — |
| FY2024 | −$2.57 | — |
| FY2023 | $0.54 | — |
| FY2022 | −$2.10 | — |
| FY2021 | −$1.42 | — |
| FY2020 | −$0.41 | — |
| FY2019 | −$4.28 | — |
| FY2018 | −$4.93 | — |
| FY2017 | −$0.27 | — |
Quarterly newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| Sep 2026 | −$0.50 | — |
| Jun 2026 | $0.08 | — |
| Mar 2026 | −$0.81 | — |
| Dec 2025 | $0.44 | — |
| 27 more quarters | Free account |
Against its own ten years
EPS (diluted) against peers
| Company | EPS (diluted) |
|---|---|
| OMCL Omnicell, Inc. compare | $0.96 |
| HSTM HealthStream, Inc. compare | $0.70 |
| PRVA Privia Health Group, Inc. compare | $0.27 |
| OMDA Omada Health, Inc. compare | $0.05 |
| GDRX GoodRx Holdings, Inc. compare | $0.04 |
| CERT Certara, Inc. compare | −$0.42 |
| SDGR Schrodinger, Inc. | −$0.79 |
| TDOC Teladoc Health, Inc. compare | −$0.86 |
| HTFL Heartflow, Inc. compare | −$1.83 |
What EPS (diluted) is
Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.
Reported line item
More on SDGR
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement